0001437749-24-010679.txt : 20240402 0001437749-24-010679.hdr.sgml : 20240402 20240402172938 ACCESSION NUMBER: 0001437749-24-010679 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240328 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marshall Dennis E CENTRAL INDEX KEY: 0001361115 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19709 FILM NUMBER: 24815810 MAIL ADDRESS: STREET 1: 3500 W. GARRY AVENUE CITY: SANTA ANA STATE: CA ZIP: 92705 FORMER NAME: FORMER CONFORMED NAME: Marshall Dennis DATE OF NAME CHANGE: 20060428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLARGO, INC. CENTRAL INDEX KEY: 0000880242 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 650159115 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14921 CHESTNUT ST. CITY: WESTMINSTER STATE: CA ZIP: 92683 BUSINESS PHONE: 888 400-2863 MAIL ADDRESS: STREET 1: 14921 CHESTNUT ST. CITY: WESTMINSTER STATE: CA ZIP: 92683 FORMER COMPANY: FORMER CONFORMED NAME: NUWAY MEDICAL INC DATE OF NAME CHANGE: 20030205 FORMER COMPANY: FORMER CONFORMED NAME: NUWAY ENERGY INC DATE OF NAME CHANGE: 20010815 FORMER COMPANY: FORMER CONFORMED NAME: LATIN AMERICAN CASINOS INC DATE OF NAME CHANGE: 19960520 4 1 rdgdoc.xml FORM 4 X0508 4 2024-03-28 0000880242 BIOLARGO, INC. BLGO 0001361115 Marshall Dennis E 14921 CHESTNUT ST. WESTMINSTER CA 92683 1 0 Option to Purchase Common Stock 0.35 2024-03-28 4 A 0 64176 A 2024-03-28 2034-03-28 Common Stock 64176 4163685 D Option to Purchase Common Stock 0.35 2024-03-31 4 A 0 53571 A 2024-03-31 2034-03-31 Common Stock 53571 4217256 D This Option was granted to Reporting Person to replace an option to purchase 52,536 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee. Total reflects the expiration of options to purchase 52,536 shares that recently expired. This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan. /s/ John R. Browning, attorney-in-fact 2024-04-02